When we think of cystic fibrosis, we might think of someone coughing, trying to clear mucus from their lungs. But that’s not the whole story.
Articles on Cystic fibrosis
Displaying all articles
On DNA Day, Canada should be inspired by the lifesaving discoveries of its researchers. However, lack of funding threatens Canadian researchers’ ability to meet the challenges of the future.
Pioneered by the Human Cell Atlas consortium, our understanding of the human body is about to be transformed – and with it, the way we treat and prevent disease
Unlocking the genetic cause of cystic fibrosis, and identifying treatments, has moved the prognosis from near certain death in infancy, to a median survival in Canada of 52 years.
Controlled coughing can help people with cystic fibrosis, under supervision and in hospital. But when done at home, it could help spread the coronavirus.
Bacteria are becoming resistant to even the most powerful antibiotics. These expensive, hard-to-treat infections are prompting physicians to reassess using viruses to destroy bacteria.
Galaxy images and patient records can be equally confusing. Now a team of astrophysicists have realised their methods could help medical professionals.
Cystic fibrosis is the most common genetic disease among Caucasians. Now scientists believe they have discovered the origin of this often lethal genetic mutation and how it spread throughout Europe.
Triclosan, an ingredient in soap and many household cleansers, has gained a bad reputation. A recent study looking for a way to boost an antibiotic, however, found that tricloscan did a great job.
Only one Canadian has ever received the Nobel Prize for medicine, in 1923. But Canadian discoveries have been essential to stem cell research, gene sequencing and treatments for cancer.
Cystic fibrosis, spinal muscular atrophy and fragile X syndrome are serious diseases, and most couples carrying the genetic mutations for these don’t know it. Should they all be tested?
While there are similarities in the general principles of palliative care provided to children and adults, there are also key differences.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
Wider availability of the cystic fibrosis drug Kalydeco since May 1, 2017 means younger patients can now access it.
Cystic fibrosis (CF) affects around 3,000 people in Australia and 70,000 worldwide. It’s an inherited disease caused by a mutation in a single gene called CFTR.
Rare diseases are yielding secrets about very common conditions.
Understanding the bugs in our lungs could help treat certain diseases, including asthma.
What if you could take a simple test to reveal your individual risk of developing a range of cancers and hundreds of other diseases?
A small plastic chip with the capacity to house various strains of bacteria may help successfully treat infection in cystic…
A study assessing the attitudes of would-be Victorian parents to screening for cystic fibrosis (CF) has found that most believe…
Top contributors
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Senior research fellow, Adelaide University
-
Associate Professor of Microbiology, Michigan State University
-
Senior lecturer in Paediatric Neurology, UNSW
-
Professor of Pediatrics and Population Health Sciences, University of Wisconsin-Madison
-
Chief Medical Scientist and Team Leader, CF Airway Research Group, 2000-2024, Adelaide University
-
Dean of the Faculty of Medicine and Health Sciences, University of Nottingham
-
Associate Professor and Program Authority, UNSW
-
Phd Student in Population Genetics, The University of Western Australia
-
Respiratory and Sleep Medicine Physician; Clinical Lecturer, University of Sydney
-
Professor of Astrophysics, University of Sussex
-
Professor of Anatomy, Lancaster University
-
Lab Head, Gynaecological Cancer Research Group, Lowy Cancer Rearch Centre, UNSW
-
Professor, The University of Western Australia
-
Research Fellow, The University of Western Australia